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Coincident with an increasing national interest in equi-
table health care, a number of studies have described
disparities in access to solid organ transplantation for
minority patients. In contrast, relatively little is known
about differences in posttransplant outcomes between
patients of specific racial and ethnic populations.
In this paper, we review trends in access to solid or-
gan transplantation and posttransplant outcomes by
organ type, race and ethnicity. In addition, we present
an analysis of categories of factors that contribute to
the racial/ethnic variation seen in kidney transplant
outcomes. Disparities in minority access to transplan-
tation among wait-listed candidates are improving,
but persist for those awaiting kidney, simultaneous
kidney and pancreas and intestine transplantation. In
general, graft and patient survival among recipients of
solid organ transplants is highest for Asians and His-
panic/Latinos, intermediate for whites and lowest for
African Americans. Although much of the difference
in outcomes between racial/ethnic groups can be ac-
counted for by adjusting for patient characteristics, im-
portant observed differences remain. Age and duration
of pretransplant dialysis exposure emerge as the most
important determinants of survival in an investigation
of the relative impact of center-related versus patient-
related variables on kidney graft outcomes.
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Introduction
The existence of disparities in access to solid organ trans-
plantation among minority patients with end-stage organ
failure has been recognized for many years (1–3). However,
relatively little is known about differences in posttransplant
outcomes between patients of specific racial and ethnic
populations (4–6). Nevertheless, it is widely believed that
graft and patient survivals for minority transplant recipients
are inferior to those observed for whites. In this paper,
we will review trends in access to solid organ transplan-
tation and posttransplant outcomes by race and ethnicity
for candidates and recipients of kidney, liver, heart, lung,
simultaneous kidney and pancreas, pancreas-alone and
intestine transplants. Specific differences by race and
ethnicity in access, transplant trends and outcomes are
demonstrated. In addition, we will present an analysis
of the relative contribution of center- and patient-related
factors on the racial/ethnic variation seen in kidney graft
outcomes.
Methods
These analyses are based on the Organ Procurement and Transplanta-
tion Network/Scientific Registry of Transplant Recipients (OPTN/SRTR)
database, which includes information on all wait-listed transplant can-
didates, transplant recipients and donors in the United States (7). The
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OPTN/SRTR data source was supplemented with end-stage renal disease
(ESRD) statistics from the Centers for Medicare and Medicaid Services
(CMS) and with vital status information from the Social Security Death
Master File (SSDMF). (For survival adjustments and diagnosis categories,
see Tables TN-4 and TN-5 in the Technical Notes of the OPTN/SRTR Annual
Report [8].) The models for time at risk for graft and patient survival began
on the date of transplant. Graft failure for kidney transplants was defined as
the earliest date among death, retransplant of the same organ type or initi-
ation of maintenance dialysis. Adjusted survival probabilities for each organ
type by race/ethnicity were computed using separate Cox regression mod-
els, with adjustments for age, sex and primary diagnosis. Analyses were
performed in SAS 9.2 (SAS Institute, Cary, NC). Following the OPTN data
collection format, Hispanic and non-Hispanic blacks were counted as African
American. Hispanic and non-Hispanic Asians were counted as Asians. Non-
Hispanic whites (whites) and Hispanic whites (Hispanic/Latinos) were tab-
ulated and evaluated separately. Results for Native Americans and patients
of other racial/ethnic groups are not reported because of small numbers.
Results
Kidney transplant trends and outcomes
Access to kidney transplantation: The number and dis-
tribution by race/ethnicity for three representative years
is shown for active waiting-list patients and transplants
for seven organ types (kidney, liver, heart, lung, kidney–
pancreas, pancreas and intestine) in Table 1. Deceased
donor (DD) kidney transplant percentages for African Amer-
icans, Hispanic/Latinos and Asians lag behind their respec-
tive proportions of the waiting list. With an ideal kidney
allocation system, there would be no barriers to trans-
plantation except for the availability of donor organs. A
consequence of such a system would be that, over time,
the proportion of racial/ethnic groups receiving transplants
Table 1: Active waiting list and deceased donor transplants by organ type and race/ethnicity, 2000–2008
2000 2004 2008
Organ
Race/ethnicity WL1 TX2 WL1 TX2 WL1 TX2
Kidney (N) 36 951 8124 45 475 9357 48 677 10 551
White (%) 42.7 53.7 38.9 48.8 37.9 46.3
African American (%) 36.5 28.7 35.9 29.5 34.1 30.9
Hispanic/Latino (%) 13.2 11.4 16.2 14.0 18.1 15.4
Asian (%) 6.5 5.1 7.6 6.1 8.5 6.1
Liver (N) 12 049 4595 12 627 5848 12 198 6069
White (%) 75.3 74.0 72.3 71.8 71.4 69.7
African American (%) 7.1 9.0 7.1 10.0 6.8 10.3
Hispanic/Latino (%) 12.6 12.9 15.2 12.5 16.5 13.9
Asian (%) 4.4 3.3 4.8 4.9 4.5 5.0
Heart (N) 2477 2199 1808 2015 1406 2163
White (%) 79.3 77.2 74.9 70.4 73.5 65.5
African American (%) 13.4 13.3 14.9 16.8 16.6 20.2
Hispanic/Latino (%) 6.0 6.7 7.7 9.0 7.3 9.9
Asian (%) 0.8 2.2 1.9 2.8 1.6 3.3
Lung (N) 2429 941 2315 1157 1006 1478
White (%) 85.5 89.7 83.6 86.2 83.5 83.1
African American (%) 9.7 7.1 9.5 7.6 9.1 8.9
Hispanic/Latino (%) 3.4 2.7 5.1 5.0 5.4 5.5
Asian (%) 1.2 0.2 1.4 0.8 1.5 1.6
Intestine (N) 71 82 127 152 168 185
White (%) 59.2 61.0 66.1 68.4 60.7 67.0
African American (%) 25.4 17.1 15.7 11.2 22.6 16.8
Hispanic/Latino (%) 11.3 19.5 14.2 15.1 13.1 11.4
Asian (%) 4.2 2.4 2.4 3.9 2.4 3.2
SPK3 (N) 1818 915 1907 881 1349 836
White (%) 80.9 84.9 70.7 75.3 66.5 70.7
African American (%) 12.2 9.2 18.4 14.1 16.1 17.0
Hispanic/Latino (%) 5.3 4.8 8.8 8.9 13.3 10.5
Asian (%) 1.0 0.4 1.4 1.1 3.0 1.2
Pancreas4 (N) 359 439 836 603 474 437
White (%) 87.5 92.3 85.9 88.4 80.6 80.6
African American (%) 7.2 3.9 6.7 5.1 11.2 11.4
Hispanic/Latino (%) 3.9 3.4 6.6 5.5 6.8 6.4
Asian (%) 1.1 0.2 0.4 0.7 0.6 1.1
Source: OPTN/SRTR special analysis, September 2009; data as of May 2009. Reference Tables 5.1a, 5.4, 6.1a, 6.4, 7.1a, 7.4, 8.1a, 8.4,
9.1a, 9.4, 10.1a, 10.4, 11.1a, 11.4, 12.1a and 12.4.
1Patients with active waiting list status at the end of the prior year.
2Transplants performed during the given year.
3Simultaneous pancreas and kidney transplants.
4Includes pancreas-transplant-alone (PTA) and pancreas-after-kidney (PAK) transplants.






























































Source: OPTN/SRTR Special Analysis, September 2009; data as of May 2009
Figure 1: Ratio of percent of kidney transplants and percent on active waiting list at end of prior year, 2000–2008.
would approximate the proportions of the same groups
on the waiting list. In such a system, the ratio of the pro-
portion transplanted to the proportion wait-listed would
approach one. Significant deviations from a value of one
would suggest the presence of barriers or advantages in
access to transplantation for a particular group. To eval-
uate racial/ethnic access to kidney transplantation, the
proportion of DD transplant recipients from each of the
reported racial/ethnic groups (white, African American, His-
panic/Latino and Asian) during three representative years
(2000, 2004 and 2008) was divided by the proportion of pa-
tients on the waiting list from the same group on Decem-
ber 31 of the preceding year. The results are expressed as
ratios and are shown for kidney transplantation in Figure 1.
Similar results are presented for the other organ types later
in this paper. A value over 1.0 indicates that more patients
of a racial/ethnic group received DD organs than would be
expected from that group’s proportion of the waiting list.
Conversely, a value below 1.0 signifies that the group has
received DD transplants at a rate below its prevalence on
the waiting list. Among kidney transplant recipients, whites
were transplanted at a rate greater than their representa-
tion on the waiting list. In contrast, African Americans, His-
panic/Latinos and Asians were transplanted at rates lower
than expected from their waiting-list prevalence. The differ-
ence between the ethnic/racial composition of the waiting
list and the distribution of kidney transplant recipients ap-
pears to be narrowing over time for whites and African
Americans; it is stable among Hispanics/Latinos but may
be increasing for Asians.
Kidney transplant trends: Between 1999 and 2006,
the total number of kidney transplants increased for all
race/ethnicity groups. However, between 2006 and 2008,
the number of white recipients of standard criteria donor
(SCD) transplants declined from 4180 in 2006 to 4017 in
2008; the number of white recipients also declined for ex-
panded criteria donor (ECD) transplants from 905 in 2006 to
867 in 2008 and for living donor (LD) transplants from 4463
in 2004 to 3995 in 2008 [Tables 5.4a, 5.4b and 5.4d]. The
numbers of SCD and LD kidney transplants performed in
the other racial/ethnic groups, in general, remained more
stable or increased slightly; the number of ECD kidney
transplants continued to increase for African Americans
and Hispanic/Latinos, perhaps as a consequence of the
OPTN policy that largely allocates ECD kidneys based upon
waiting time alone.
Kidney graft and recipient survival: Graft outcomes var-
ied by racial/ethnic group irrespective of donor type, and
the differences tended to increase with time after trans-
plant. As shown in Figure 2, adjusted DD 3-month graft
survival was very similar among the four race/ethnicities.
One-year adjusted DD graft survival ranged from 89% to
94%; the percentages for 5- and 10-year adjusted DD graft
survival were from 62% to 76% and 32% to 54%, re-
spectively. At each of these timepoints, Asian kidney re-
cipients enjoyed the highest adjusted and unadjusted (not
shown) graft survival, followed by Hispanic/Latinos, and
then whites. African American recipients had the lowest
graft survival at each interval shown.
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Source: 2009 OPTN/SRTR Annual Report, Table 5.8c
*Transplants 2006-2007 used to calculate 1 year 
survival, 2002-2007 for 5 year survival, and 
1997-2007 for 10 year survival.
Figure 2: Adjusted deceased donor
kidney graft survival by race/ethnicity.
Graft survival after LD transplantation followed a similar
pattern. The adjusted LD kidney transplant graft survival at
3 months was 98% overall, ranging from 98% to 99%
[Table 5.10d]. One-year adjusted LD graft survival was
96% overall, ranging from 95% to 98%; 5-year adjusted
LD graft survival was 81% overall, ranging from 73% to
89% and 10-year adjusted LD graft survival was 59% over-
all, ranging from 45% to 70% [Table 5.10d]. Although LD
graft survival was excellent for all groups at 3 months,
differences developed by 1 year. As with DD kidney trans-
plantation, Asian recipients enjoyed the highest adjusted
LD graft survival, followed by Hispanic/Latinos, and then
whites, with African Americans displaying the poorest
outcomes.
Notably, the gap between DD graft survival for African
Americans and other racial/ethnic groups appeared to be
narrowing. Both DD and LD (LD, not shown) graft survival
improved more rapidly for African Americans than for other
racial/ethnic groups. Table 2 shows outcomes among kid-
ney transplant recipients for 1996–2001 and 2002–2007.
The overall 5-year adjusted DD kidney transplant graft sur-
vival improved by 6% for African Americans (from 56% to
62%); likewise, improvement was 4% for Hispanic/Latinos
(71% to 75%), 2% for Asians (74% to 76%) and 3% for
whites (68% to 71%).
Long-term, adjusted DD patient survival among African
Americans and whites were similar with both groups,
lagging behind the 10-year survival rates seen for His-
panic/Latino and Asian transplant recipients (Figure 3). In
the first year following kidney transplant, adjusted recipi-
ent survivals were tightly grouped from 96% to 98% for
the four ethnic groups considered. By the fifth year post-
transplant, Hispanic/Latino and Asian recipients demon-
strate superior patient survivals when compared with ei-
ther white or African American recipients at 89% and 87%
versus 82% and 82%, respectively. By 10 years posttrans-
plant, this difference increased as whites and African Amer-
icans had 60% and 57% patient survival, respectively, com-
pared with Asians at 71% and Hispanic/Latinos at 68%.
Receipt of an LD kidney was associated with an al-
most 100% 3-month and 99% 1-year patient survival
for each racial/ethnic group. At 5 and 10 years after
transplantation, the adjusted patient survivals among
African American (91% and 73%, respectively) and white
recipients (92% and 77%, respectively) were inferior to the
patient survival seen for Hispanic/Latino (95% and 83%,
respectively) and Asian recipients (95% and 84%, respec-
tively) [Table 5.12d].
Comparing 5-year trends (1996–2001 vs. 2002–2007) in
adjusted DD kidney recipient survival, 3% improvements
were seen for African Americans (79% to 82%) and His-
panic/Latinos (85% to 88%), whereas Asians improved
by 2% (86% to 88%) and whites by 1% (81% to 82%)
(Table 2).
In summary, among kidney transplant recipients, several
trends are evident. First, the disparity in access to DD kid-
ney transplantation between wait-listed white and minority
patients appears to be narrowing significantly for African
Americans, but less so for Hispanic/Latinos and Asians.
Asian and Hispanic/Latino recipients demonstrated consis-
tently superior long-term DD and LD graft and patient sur-
vivals compared with white recipients. African American
recipients have consistently inferior long-term LD and DD
graft survival relative to other racial/ethnic groups. Factors
contributing to differences in posttransplant graft survival
will be examined in detail later in this paper. Finally, DD
kidney graft and patient survival is improving more rapidly
for African Americans and Hispanic/Latinos than for whites
and Asians.
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Table 2: Adjusted deceased donor graft and patient survival at 5 years by organ and race/ethnicity for transplant recipients from 1996 to
2001 and 2002 to 2007
1996–2001 2002–2007
5-year 5-year
Organ Race/ethnicity N survival (%) N survival (%)
Kidney graft Overall 47 073 65.5 55 513 69.2
White 25 912 68.3 26 726 70.9
African American 13 253 56.4 17 022 62.2
Hispanic/Latino 5115 70.8 7740 75.0
Asian 2313 73.7 3265 76.3
Kidney patient Overall 40 516 81.0 48 242 83.5
White 21 612 80.8 22 388 82.4
African American 11 829 79.0 15 242 82.1
Hispanic/Latino 4502 85.2 6932 88.4
Asian 2124 86.0 2997 87.6
Liver patient Overall 22 667 72.0 29 604 73.8
White 17 117 72.6 21 269 74.1
African American 1942 64.8 2778 66.8
Hispanic/Latino 2583 72.5 3860 75.2
Asian 868 73.3 1445 78.1
Heart patient Overall 12 915 72.8 11 991 75.2
White 10 129 74.8 8478 77.7
African American 1697 61.9 2062 64.8
Hispanic/Latino 773 71.6 1016 75.1
Asian 259 75.0 339 75.9
Lung patient Overall 5228 44.5 7199 53.5
White 4670 45.3 6194 53.2
African American 357 33.9 558 57.5
Hispanic/Latino 155 46.8 326 49.4
Asian 30 56.2 77 61.4
Source: OPTN/SRTR special analysis, September 2009; data as of May 2009.
Liver transplant trends and outcomes
Access to liver transplantation: Different patterns were
seen in access to liver transplantation among wait-listed
candidates than those observed for kidney transplanta-
tion (Figure 4). Among liver transplant recipients, whites
were transplanted at a rate commensurate with their pro-
portion on the waiting list. However, African Americans
and, most recently, Asians were transplanted at rates
above their representation on the waiting list. Further-
more, liver transplantation rates relative to whites and His-
panic/Latinos appeared to be increasing for Asians and





















White African American Hispanic/Latino Asian
Source: 2009 OPTN/SRTR Annual Report, Table 5.12c
*Transplants 2006-2007 used to calculate 1 year 
survival, 2002-2007 for 5 year survival, and 
1997-2007 for 10 year survival.
Figure 3: Adjusted deceased donor
kidney patient survival by race/
ethnicity.
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Figure 4: Ratio of percent of liver transplants and percent on active waiting list at end of prior year, 2000–2008.
at which Hispanic/Latinos received liver transplants de-
creased between 2000 and 2008 relative to their rep-
resentation on the waiting list. In 2008, the liver trans-
plant rate deficit was 16% for Hispanic/Latinos and 2% for
whites in comparison with their waiting-list representation,
whereas African Americans and Asians received 51% and
11% more liver transplants, respectively, than would be
predicted based upon their waiting-list prevalence. Impor-
tantly, these results were not adjusted for patient charac-
teristics including MELD scores.
Liver transplantation trends: The total number of liver
transplants (DD and LD) gradually increased from 4751 in
1999 to a peak of 6651 in 2006, but declined slightly over
the past 2 years, falling to 6318 in 2008 [Tables 9.4a and
9.4b]. This decrease principally reflected a drop in the num-
ber of liver transplants for whites, as the number of liver
transplants going to the other race/ethnicities remained
relatively stable. As a consequence, the ethnic/racial dis-
tribution of DD liver transplant recipients has changed,
with a decline in white recipients from 76% in 1999 to
70% in 2008 balanced by modest increases in the per-
centage transplanted for African Americans, Asians and
Hispanic/Latinos [Table 9.4a]. The number of LD liver trans-
plants declined from a peak of 524 in 2001 to a low of 249 in
2008 [Table 9.4b]. LD liver transplants now comprise less
than 4% of liver transplants performed nationally, with the
preponderance in 2008 going to whites (189, [76%]), and
very few to African Americans (20, [8%]), Hispanic/Latinos
(26, [10%]) and Asians (14, [6%]).
Liver transplant recipient survival: As seen with kid-
ney transplantation, patient survival varied by racial/ethnic
group (Figure 5). The adjusted 3-month patient survival for
DD liver transplants in 2006–2007 was 94%, with little dif-
ference between racial/ethnic groups [Table 9.12a]. Patient
survival for white recipients was 88% at 1 year and 74%
at 5 years; African American recipients had similar 1-year,
but lower 5-year patient survival (87% and 67%, respec-
tively) (Figure 5). In contrast, Asian and, to a lesser extent,
Hispanic/Latino recipients had superior outcomes. One-
and five-year patient survival was 89% and 75%, respec-
tively, for Asians and 91% and 78% for Hispanic/Latinos.
By 10 years, patient survival was 68% for Asians, 62%
for Hispanic/Latinos, 59% for whites and 51% for African
Americans.
As with kidney transplantation, there was a trend toward
improved 5-year adjusted overall DD patient survival when
transplants from 1996 through 2001 (66%) were compared
with those performed in the interval of 2002–2007 (69%)
(Table 2). The largest increments in liver transplant pa-
tient survival occurred with Asians (73–78%), with lesser
improvements in Hispanic/Latinos (73–75%) and African
Americans (65–67%), whereas little improvement was ob-
served in recipient survival for whites (73–74%).
In summary, access to DD liver transplantation for African
Americans and Asians was above and access for His-
panic/Latinos was below their proportional representa-
tion on the waiting list. The numbers of DD liver
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Source: 2009 OPTN/SRTR Annual Report, Table 9.12a
*Transplants 2006-2007 used to calculate 1 year 
survival, 2002-2007 for 5 year survival, and 
1997-2007 for 10 year survival.
Figure 5: Adjusted deceased donor
liver patient survival by race/ethnicity.
transplants declined for whites, but remained stable for
other racial/ethnic groups. The overall number of LD liver
transplants decreased. Few racial/ethnic minorities re-
ceived LD liver transplants. Similar to kidney transplan-
tation, DD patient survival differed between racial/ethnic
groups, and the differences increased over time. African
Americans demonstrated the poorest and Asians the best
DD posttransplant survival. DD Liver transplant results are
improving, more so for Asians and Hispanic/Latinos than
for whites and African Americans.
Heart transplant trends and outcomes
Access to heart transplantation: Access to cardiac trans-
plantation appears different from both kidney and liver
transplantation (Figure 6). Asians, Hispanic/Latinos and
African Americans were all transplanted at rates above
their representation on the waiting list. Conversely, whites
were transplanted less often than their frequency on the
waiting list, and the rate for whites declined during the
study period. These results were not adjusted for recipient

























































Figure 6: Ratio of percent of heart transplants and percent on active waiting list at end of prior year, 2000–2008.
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Source: 2009 OPTN/SRTR Annual Report, Table 11.12
*Transplants 2006-2007 used to calculate 1 year 
survival, 2002-2007 for 5 year survival, and 
1997-2007 for 10 year survival.
Figure 7: Adjusted heart patient sur-
vival by race/ethnicity.
Heart transplant trends: As shown in Table 1, the num-
ber of cardiac transplants declined slightly, from 2199 in
2000 to 2163 in 2008. The proportion among whites de-
clined, whereas the proportion among African Americans,
Hispanic/Latinos and Asians increased during this time.
Accordingly, the racial/ethnic distribution of the recipients
changed, with white patients receiving 79% of cardiac
transplants in 2000 and 66% in 2008. In contrast, the per-
centage of African American, Asian and Hispanic/Latino
cardiac transplant recipients all increased. African Ameri-
cans comprised 13% of the recipients in 2000 and 20% in
2008. Cardiac transplants to Asian patients increased from
2% to 3%, whereas Hispanic/Latino recipients increased
from 7% to 10%.
Heart transplant recipient survival: Overall adjusted car-
diac patient survival at 1 and 5 years was 88% and 75%,
respectively [Table 11.12]. Again, there were differences
in patient outcomes between racial/ethnic groups that in-
creased over time (Figure 7). Short-term patterns were
similar to those seen with kidney and liver transplanta-
tion. Among transplant recipients in 2006–2007, adjusted
patient survival at 3 months and 1 year was highest among
Asians, followed by Hispanic/Latinos, whites and then
African Americans. Outcomes at 10 years followed this
trend, with patient survival 65% for Asians, 61% for His-
panic/Latinos, 59% for whites and 42% for African Amer-
icans. Interestingly, at 5 years, white recipients had the
best patient survival (77%), followed by Asians (75%), His-
panic/Latinos (75%) and African Americans (65%).
As with kidney and liver transplantation, there was a trend
toward improved 5-year adjusted overall patient survival
when transplant survival for recipients from the interval
of 1996–2001 (73%) was compared with survival for re-
cipients in the interval from 2002 to 2007 (75%); this is
shown in Table 2. The largest improvements were seen
with whites (75–78%), African Americans (62–65%) and
Hispanic/Latinos (72–75%).
In summary, African Americans, Asians and Hispanic/
Latinos all received heart transplants at rates that exceeded
their proportion of the waiting list. Although the total num-
ber of heart transplants performed has been stable, the
percentage of heart transplants going to minorities has
increased. Five-year patient survival was best for whites
and better for Hispanic/Latinos and Asians than for African
Americans. Ten-year patient survival was highest for Asians
and Hispanics, and intermediate for whites. The biggest
improvements in 5-year graft survival were seen for whites,
African Americans and Hispanic/Latinos.
Lung transplant trends and outcomes
Nationally, there were very few minority lung transplant re-
cipients from 1999–2008 (ranging from 10% to 17%) (Table
12.4). The small numbers limit opportunities for analysis
of access to transplant, transplant trends and differences
in graft and patient survival between racial/ethnic groups.
By 2008, gaps in access seen earlier in the decade for
racial/ethnicity minorities resolved (Figure 8). Of the 1478
lung recipients in 2008, 83% were white, 9% African Amer-
ican, 6% Hispanic/Latino and 2% Asian; these percentages
closely approximated the racial/ethnic composition of the
active waiting list (Table 1).
DD lung transplant patient survival outcomes also differed
by race/ethnicity (Figure 9). Adjusted patient survival was
similar at 1-year among whites and African Americans
(84% and 84%, respectively), intermediate among His-
panic/Latinos (82%) and lowest for Asians (78%). At 5
years, adjusted patient survival was 53% for whites, 57%
for African Americans, 49% for Hispanic/Latinos and 61%




























































Figure 8: Ratio of percent of lung transplants and percent on active waiting list at end of prior year, 2000–2008.
for Asians. Ten-year adjusted transplant survival ranged
from 32% for Hispanic/Latinos to 25% for African Ameri-
cans. Table 2 shows that comparisons in adjusted five-year
patient survival between the 1996–2001 and 2002–2007
cohorts demonstrated large improvements for whites (45–
54%) and African Americans (34–58%). Improvements
were more modest among Hispanic/Latinos (47–49%) and
Asians (56–61%).
Pancreas transplant alone, pancreas after kidney and
simultaneous kidney and pancreas transplant trends
and outcomes
In 2008, 223 pancreas transplants alone (PTA), 214 pan-
creas after kidney (PAK) and 836 simultaneous kidney–
pancreas (SPK) transplants were performed [Tables 6.4,
7.4, 9.4]. These small samples produce uncertainty in





















White African American Hispanic/Latino Asian
Source: 2009 OPTN/SRTR Annual Report, Table 12.12
*Transplants 2006-2007 used to calculate 1 year 
survival, 2002-2007 for 5 year survival, and 
1997-2007 for 10 year survival.
Figure 9: Adjusted deceased donor
lung patient survival by race/ethnicity.
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Figure 10: Ratio of percent of SPK transplants and percent on active waiting list at end of prior year, 2000–2008.
transplant and patient survival, particularly for PTA and PAK
transplants and for Asian recipients. For PTA in 2008, 80%
went to whites, 10% to African Americans, 2% to Asians
and 7% to Hispanic/Latinos. The racial/ethnic distribution
of PAK in 2008 was very similar to PTA, as 81% of the
PAK recipients were white, 13% African American, 1%
Asian and 6% Hispanic/Latino [Tables 6.4, 7.4, 8.4]. For
both PTA and PAK, the racial/ethnic distribution of recipi-
ents appeared to parallel the active waiting list (not shown).
Few minorities received SPK transplants (Table 1); on a per-
centile basis, 71% of recipients were white, 17% African
American, 1% Asian, and 11% were Hispanic/Latino
(Table 1). Most recently, whites and African Americans ap-
peared to be transplanted at a slightly higher rate, and His-
panic/Latinos and Asians minorities at substantially lower
rates than expected by their prevalence on the waiting list
(Figure 10).
PTA and PAK survival for different racial/ethnic groups were
not compared, given the very small number of minority re-
cipients. One-year adjusted SPK kidney graft survival was
93% for whites, 89% for African Americans, 100% for
Asians (although the number of recipients was only 23)
and 91% for Hispanic/Latinos (Figure 11). The 1-year SPK
pancreas graft survival was lower, at 85% for whites, 83%
for African Americans, 91% for Asians and 87% for His-
panic/Latinos (Figure 12). At 5 years, the adjusted SPK kid-
ney graft survival ranged from 88% for Asians to 68% for
African Americans. Whites and Hispanic/Latinos were at
81% and 78%, respectively. Five-year SPK pancreas graft
survival varied from 84% for Asians to 66% for African
Americans, with whites at 74% and Hispanic/Latinos at
77%. At 10 years, SPK kidney graft survival was very sim-
ilar for Hispanic/Latinos (61%), Asians (63%) and whites
(60%), but only 51% for African Americans. SPK pan-
creas graft survival varied from 59% for Asians, 57% for
Hispanic/Latinos and 56% for whites, to 49% for African
Americans.
One-year adjusted SPK patient survival was 96% for
whites, 95% for African Americans and Hispanic/Latinos,
and 100% for Asians (Figure 13). Five-year adjusted patient
survival was 94% for Asians, 89% for Hispanic/Latinos,
88% for whites and 83% for African Americans. Ten-year
adjusted patient survival ranged from 77% for Asians, 74%
for Hispanic/Latinos and 72% for whites, to 67% for African
Americans.
Intestine transplant trends and outcomes
There were only 168 intestine candidates on the intestine
waiting list at the end of 2008, and only 185 intestinal trans-
plants were performed nationally in 2008 (Table 1). Among
these candidates, 61% were white, 23% were African
American, 2% Asian and 13% Hispanic/Latino. Of these
recipients, 67% were white, 17% were African Ameri-
can, 3% Asian and 11% Hispanic/Latino. Adjusted patient
survival, especially for Asians, are based upon very small
numbers. At 1 year, adjusted patient survival was 80% for






















White African American Hispanic/Latino Asian
Source: 2009 OPTN/SRTR Annual Report, Table 8.8
*Transplants 2006-2007 used to calculate 1 year 
survival, 2002-2007 for 5 year survival, and 
1997-2007 for 10 year survival.
Figure 11: Adjusted deceased donor
SPK kidney graft survival by race/
ethnicity.
whites, 79% for Hispanic/Latinos, 78% for African Ameri-
cans and 72% for Asians. Patient survival at 5 years was
65% for Hispanic/Latinos, 57% for whites, 58% for Asians
and 55% for African Americans. At 10 years, survival was
48% for Asians, 45% for whites, 44% for Hispanic/Latinos
and 40% for African Americans (Figure 14).
Kidney Transplant Outcomes: Special
Analysis
Methods
To identify and quantify factors contributing to racial and
ethnic differences in kidney transplant outcomes, the rela-
tive risks (RRs) of DD kidney graft failure at 5 years post-
transplant were examined using multiple Cox proportional
hazards regression models for adult recipients of primary
solitary DD kidney transplants performed between Jan-
uary 1, 2000 and December 31, 2007. Data were recorded
at the time of transplant. Recipients were excluded from
analysis if they were younger than 18 years of age at trans-
plantation, had previously received a kidney or extra-renal
transplant, or underwent an LD or multiorgan transplant.
Graft failure was defined as the earliest date of graft fail-
ure (as determined by OPTN/SRTR or CMS data) or death
(as determined by OPTN/SRTR, CMS or SSDMF data).
Individuals were censored at the earliest of the date of
5 years posttransplant, last follow-up, or the end of the
study (December 31, 2008). The RR of graft failure for three
racial/ethnic groups (African American, Hispanic/Latino and
Asian) were determined and referenced to the RR for
whites. The RR for Other racial/ethnic group is not shown





















White African American Hispanic/Latino Asian
Source: 2009 OPTN/SRTR Annual Report, Table 8.8
*Transplants 2006-2007 used to calculate 1 year 
survival, 2002-2007 for 5 year survival, and 
1997-2007 for 10 year survival.
Figure 12: Adjusted deceased donor
SPK pancreas graft survival by race/
ethnicity.
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White African American Hispanic/Latino Asian
Source: 2009 OPTN/SRTR Annual Report, Table 8.12
*Transplants 2006-2007 used to calculate 1 year 
survival, 2002-2007 for 5 year survival, and 
1997-2007 for 10 year survival.
Figure 13: Adjusted deceased donor
SPK patient survival by race/ethnicity.
The main analyses focus on the RR of graft failure for
the racial/ethnic groups of white, African American, His-
panic/Latino and Asian kidney transplant recipients, com-
paring an unadjusted model and several adjusted models.
Each adjusted model includes combinations of categories
of variables as described in Table 3. To better understand
the differential effects of patient- and center-related char-
acteristics on kidney transplant outcomes, variables were
categorized and ranked, from those that were most as-
sociated with the characteristics of the transplant center
and most removed from the individual characteristics of
patients to those that were most specific to individual pa-
tients and distant from the characteristics of the trans-
plant center. Accordingly, variables were arranged in or-
dered categories as: center factors, OPO factors, organ
factors, transplant factors, treatment protocols, socioeco-
nomic factors, dialysis time, disease burden and patient
demographics. The variables that are included in each cat-
egory are collected by the OPTN at the time of transplan-
tation. The RR of graft failure at 5 years and the num-
ber and percentage of DD kidney transplant recipients by
racial/ethnic group for selected factors related to graft fail-
ure are shown in Table 4. The individual effects of adjust-
ment for each category of variables are shown in Table 5.
To quantify the incremental effect of different categories
of factors, RRs were sequentially analyzed using unad-
justed models and then models that adjusted for specific
categories of variables beginning with center characteris-
tics and progressing to patient characteristics (Table 6).
Finally, the models were rerun in reverse sequence,
from those most patient-specific to those most center-
specific to determine whether the order by which vari-
ables were added would influence the direction and mag-





















White African American Hispanic/Latino Asian
Source: 2009 OPTN/SRTR Annual Report, Table 10.12
*Transplants 2006-2007 used to calculate 1 year 
survival, 2002-2007 for 5 year survival, and 
1997-2007 for 10 year survival.
Figure 14: Adjusted deceased donor
intestine patient survival by race/
ethnicity.
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Table 3: Factors used in the graft outcome models
Center factors
Median waiting time (<2 years, ≥2 years, not yet reached)
Average length of stay (<7 days, ≥7 days)
Volume (in quartiles <59 transplants, 59–99 transplants,
100–165 transplants, ≥166 transplants)
Age distribution (% age 0–17, % age 18–34, % age 35–49, %
age 50–64, % age 65+)
Race/ethnicity (% White, % African American, %
Hispanic/Latino, % Asian, % Other)
PRA (% 0–9, % 10–79, % 80+, % missing)
Diagnosis (% glomerulonephritis, % diabetes, %
hypertension, % other/missing)
Percent deceased donor transplants among all kidney
transplants
OPO
OPO (58 organ procurement organizations)
Organ factors
Donor age (<40 years, 40–49 years, 50–59 years, ≥60 years)
Donor race (White, Non-White)
Donor sex (male, female)
Donor hepatitis B (yes/no)
Donor hepatitis C (yes/no)
Donor positive CMV (yes/no)
ECD (yes/no)
DCD (yes/no)
Donor cause of death (anoxia, CVA/stroke, head trauma, CNS
tumor, other)
Transplant factors
HLA mismatch A (0, 1, 2, missing)
HLA mismatch B (0, 1, 2, missing)
HLA mismatch DR (0, 1, 2, missing)
Donor-recipient weight ratio (<0.75, 0.75–0.89, 0.90–1.14,
≥1.15, missing)
Transplant year (2000–2007)
Cold ischemia time hours (0–6, >6–12, >12–18, >18–24,
>24–30, >30–36, >36, missing)
Shared (yes/no)
Pumped (yes/no)







Other maintenance immunosuppression (yes/no)
Socioeconomic factors
Recipient insurance (Medicare only, Medicaid only, Medicare
primary + other secondary, private only, private only +
other, other source of payment, missing)
Education (less than high school, high school, college, other)
Average income in zip code (<$20K, $20–29K, $30–39K,
$40–59K, ≥$60K)
Dialysis time
Time on dialysis (preemptive, ≤1 year, >1–2 years, >2–3
years, >3–5 years, >5–7 years, >7 years)
Disease burden
Diagnosis (glomerulonephritis, diabetes, hypertension, other,
missing)






Diabetes with insulin (yes/no)
Diabetes (yes/no)





Recipient age (18–34, 35–49, 50–64, 65+)
Demographic factors
Sex and previous pregnancies (male, female never pregnant,
female previously pregnant)
Blood type (A, AB, B, O)
BMI (<18.5, 18.5–24, 25–30, ≥30, missing)
Employment (yes/no)
(Table 7). All statistical analyses were performed using
SAS 9.2.
Results
Table 4 summarizes the number and percentage of 58 978
kidney transplant recipients by racial/ethnic group for se-
lected categories of statistically important variables (age,
duration of ESRD, diagnosis, hepatitis C status and insur-
ance type at transplant), and reports the overall RR of
graft failure associated with subcategories of these factors.
Whites were, on average, older and all other racial/ethnic
groups younger, than the average age of the entire kidney
transplant recipient population. The best outcomes were
seen among transplant patients between 35 and 49 years
of age; lesser and greater age was associated with higher
rates of graft failure. There was a dose-related effect of
duration of ESRD as measured by dialysis time, with an
overall twofold difference in the RR of graft loss at 5 years
between those receiving a preemptive kidney transplant
and those who undergo transplantation after seven or more
years of dialysis. In general, whites were far more likely to
receive a preemptive kidney graft and less likely to be ex-
posed to greater than 3 years of dialysis before transplan-
tation. Also of significant importance were primary ESRD
diagnosis, hepatitis C status and insurance. Compared with
the reference group of recipients with glomerulonephritis,
those with ESRD from diabetes had an increased RR of
graft loss of 1.11; those with hypertension had an RR of
1.08; and patients with other causes of ESRD had a slightly
reduced RR of 0.94. Asians were most likely to have ESRD
from glomerulonephritis, African Americans from hyper-
tension and whites from other causes. Hepatitis C was also
associated with an increased RR of 1.37, and African Amer-
icans were far more likely to be hepatitis C antibody pos-
itive at the time of transplant than recipients of the other
racial/ethnic groups. Finally, in comparison with private in-
surance only, all other types of insurance were associated
with increased RR of graft loss. Medicare-only insurance
was most common in African Americans, Medicaid-only in
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Table 4: Relative risk of deceased donor graft failure at 5 years and number and percentage of deceased donor kidney transplant







Factor RR1 N % N % N % N % N %
All 58 978 100 28 245 100 18 603 100 7 772 100 3 578 100
Recipient age
Mean age 51.8 years 54.0 years 49.5 years 49.6 years 51.3 years
18–34 years 1.25∗ 7218 12.2 2597 9.2 2755 14.8 1318 17.0 464 13.0
35–49 years (ref) 1.00 17 049 28.9 7188 25.4 6253 33.6 2333 30.0 1060 29.6
50–64 years 1.14∗ 25 099 42.6 12 479 44.2 7611 40.9 3136 40.3 1507 42.1
65+ 1.56∗ 9612 16.3 5981 21.2 1984 10.7 985 12.7 547 15.3
Recipient years of ESRD
Mean ESRD years 3.5 years 2.7 years 4.5 years 4.1 years 3.9 years
Preemptive 0.68∗ 3653 6.2 2701 9.6 414 2.2 351 4.5 166 4.6
0–1 years 0.85∗ 5232 8.9 3722 13.2 823 4.4 406 5.2 246 6.9
1–2 years (ref) 1.00 9741 16.5 5996 21.2 2147 11.5 1018 13.1 474 13.2
2–3 years 1.06∗ 10 292 17.5 5408 19.1 2940 15.8 1274 16.4 546 15.3
3–5 years 1.11∗ 16 106 27.3 6702 23.7 5702 30.7 2339 30.1 1079 30.2
5–7 years 1.29∗ 8448 14.3 2469 8.7 3711 19.9 1446 18.6 683 19.1
>7 years 1.39∗ 5506 9.3 1247 4.4 2866 15.4 938 12.1 384 10.7
Recipient diagnosis
Glomerlonephritis (ref) 1.00 12 477 21.2 6224 22.0 3400 18.3 1600 20.6 1106 30.9
Diabetes 1.11∗ 15 069 25.6 7101 25.1 4178 22.5 2573 33.1 807 22.6
Hypertension 1.08∗ 15 026 25.5 4441 15.7 7921 42.6 1721 22.1 846 23.6
Other 0.94∗ 16 312 27.7 10 453 37.0 3059 16.4 1864 24.0 810 22.6
Hepatitis C
No (ref) 1.00 55 799 94.6 27 360 96.9 16 785 90.2 7448 95.8 3452 96.5
Yes 1.37∗ 3179 5.4 885 3.1 1818 9.8 324 4.2 126 3.5
Recipient insurance
Medicare only 1.17∗ 6595 11.2 2712 9.6 2685 14.4 876 11.3 254 7.1
Medicaid only 1.28∗ 2216 3.8 523 1.9 790 4.2 607 7.8 263 7.4
Medicare (primary) + other 1.25∗ 30 309 51.4 13 219 46.8 10 322 55.5 4501 57.9 1800 50.3
Private only (ref) 1.00 9532 16.2 5810 20.6 2184 11.7 826 10.6 643 18.0
Private (prime) + other 1.12∗ 8574 14.5 5240 18.6 1987 10.7 748 9.6 507 14.2
Other source 1.08 1744 3.0 736 2.6 633 3.4 213 2.7 111 3.1
∗p < 0.05.
1Adjusted for all factors in Table 3 and race/ethnicity. Source: OPTN/SRTR special analysis, August 2009; data as of February 2009.
Hispanic/Latinos, and private-only and private-primary in-
surance in whites.
The RRs of graft failure at 5 years are shown in Ta-
bles 5–7 by race/ethnicity for one unadjusted and sev-
eral adjusted models. In each table, the RR of graft fail-
ure for African Americans, Hispanic/Latinos and Asians are
compared with the RR for whites (RR = 1.00). Without
adjustments, the RR of graft failure at 5 years when com-
pared with whites was 1.35 for African Americans, 0.83
for Hispanic/Latinos and 0.75 for Asians. All comparisons
in Tables 5–7 between the RR of graft failure for whites
and other race/ethnicities are statistically significant with a
p-value < 0.05.
Table 5 shows the independent effect of adjustment for
each category of variables. When compared with the un-
adjusted results, adjustments for age, disease burden, so-
cioeconomic status, time on dialysis prior to transplan-
tation and treatment factors modified the differences in
the RR of graft failure compared with whites among
each of the other racial/ethnic groups. Surprisingly, ad-
justments for center factors and demographic character-
istics (without age) had little or no effect on the rates
of graft failure. Transplant factors and center-alone ad-
justments affected relative survival for African Americans
and Asians, and organ factors influenced outcomes for
Asians.
Adjustment for age alone resulted in an apparent increase
in the RR of graft failure for minorities in comparison
with whites (Table 5). Because white recipients were
older, on average, than recipients from other racial/ethnic
groups (Table 4), adjustment for age likely increased the
expected number of graft failures for whites relative to mi-
norities and, therefore, resulted in higher RRs for African
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Table 5: Relative risk of graft failure at 5 years by race/ethnicity among deceased donor kidney transplant recipients, 2000–2008 (single
factors into model)
White African Hispanic/ Asian
Factor1 RR American RR∗ Latino RR∗ RR∗
No adjustment 1.00 1.35 0.83 0.75
Center alone 1.00 1.31 0.83 0.75
Center factors alone 1.00 1.29 0.82 0.74
OPO alone 1.00 1.33 0.86 0.76
Organ factors alone 1.00 1.33 0.82 0.71
Transplant factors alone 1.00 1.27 0.82 0.71
Treatment protocol alone 1.00 1.38 0.87 0.79
Socioeconomic factors alone 1.00 1.28 0.77 0.73
Dialysis time alone 1.00 1.22 0.76 0.69
Disease burden alone 1.00 1.26 0.79 0.74
Age alone 1.00 1.45 0.88 0.78
Demographic factors alone 1.00 1.33 0.82 0.77
∗p < 0.05, each row versus white.
1See Table 3 for the list of variables included in each category of variables.
Source: OPTN/SRTR special analysis, August 2009; data as of February 2009.
Table 6: Relative risk of graft failure at 5 years by race/ethnicity among deceased donor kidney transplant recipients, 2000–2008
White African Hispanic/ Asian
Factor1 RR American RR∗ Latino RR∗ RR∗
No adjustment 1.00 1.35 0.83 0.75
+Center factors 1.00 1.29 0.82 0.74
+OPO factors 1.00 1.30 0.83 0.75
+Organ factors 1.00 1.29 0.84 0.73
+Transplant factors 1.00 1.23 0.84 0.72
+Treatment protocol 1.00 1.24 0.84 0.73
+Socioeconomic factors 1.00 1.19 0.79 0.73
+Dialysis time 1.00 1.13 0.77 0.71
+Disease burden 1.00 1.07 0.74 0.71
+Age 1.00 1.11 0.77 0.73
+Demographic factors 1.00 1.12 0.77 0.74
∗p <0.05, each row versus white.
1See Table 3 for the list of variables included in each category of variables.
Source: OPTN/SRTR special analysis, August 2009; data as of February 2009.
Table 7: Relative risk of graft failure at 5 years by race/ethnicity among deceased donor kidney transplant recipients, 2000–2008 (reverse
factor entry into model)
White African Hispanic/ Asian
Factor1 RR American RR∗ Latino RR∗ RR∗
No adjustment 1.00 1.35 0.83 0.75
+Demographic factors 1.00 1.33 0.82 0.77
+Age 1.00 1.43 0.87 0.80
+Disease burden 1.00 1.33 0.83 0.79
+Dialysis time 1.00 1.22 0.76 0.74
+Socioeconomic factors 1.00 1.21 0.75 0.74
+Treatment protocol 1.00 1.22 0.78 0.77
+Transplant factors 1.00 1.17 0.78 0.75
+Organ factors 1.00 1.15 0.77 0.73
+OPO 1.00 1.12 0.78 0.74
+Center factors 1.00 1.12 0.77 0.74
∗p < 0.05, each row versus white.
1See Table 3 for the list of variables included in each category of variables. Source: OPTN/SRTR special analysis, August 2009; data as of
February 2009.
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Americans, Hispanic/Latinos and Asians. In contrast,
whites had less pretransplant exposure to dialysis than
did minority recipients. Because longer time on dialysis is
associated with poorer graft survival, adjustment for time
on dialysis increased the number of expected graft failures
for African Americans, Asians and Hispanic/Latinos and de-
creased the RR of graft failure for these minority groups
relative to whites. Therefore, adjusting for age tends to in-
crease and, for duration of dialysis exposure, to decrease
the RR of graft failure for each minority in comparison with
whites.
It is also notable that adjustment for the center factors
included in these models closely parallels the results of
an adjustment for center alone. In contrast, adjustment for
age alone does not mimic the effect of adjustment for addi-
tional demographic factors among African Americans and
Hispanic/Latinos. Therefore, center-alone is not maintained
as a separate category in the stepwise analyses displayed
in Tables 6 and 7, whereas age in these analyses con-
tinues to be analyzed separately from other demographic
factors.
The RR of graft failure by race/ethnicity at 5 years is shown
for 11 models (1 unadjusted model and 10 models ad-
justed for an increasing number of factors) in Tables 6
and 7. These tables demonstrate a different method of
comparison of graft failure rates than that used in Table
5. As in Table 5, unadjusted, or crude rates for African
Americans, Hispanic/Latinos and Asians were compared
with the rates for whites (1.00). However, unlike Table 5,
the unadjusted models were followed, not by separate,
stand-alone adjusted models, but by models with step-
wise adjustments for the sets of variables under consider-
ation. In these stepwise models, each subsequent model
incorporates all of the adjustments preceding it, as sum-
marized in the row immediately above. For example, in
Table 6, the model for OPO factors also includes the ad-
justments for center factors, and the model for organ fac-
tors includes the adjustment factors for center and OPO,
etc.
In Table 6, adjustment for center factors alone reduced the
difference in the RR of graft failure observed in the un-
adjusted models between African Americans and whites.
Stepwise adjustments for OPO factors and organ charac-
teristics had little incremental effect. Further stepwise ad-
justment for transplant factors demonstrated additional ef-
fects only for African Americans, but no additive effect was
demonstrated through adjustment for treatment protocol.
With progressive adjustments for socioeconomic factors,
dialysis time and disease burden, differences in the RR
of graft failure between the unadjusted and adjusted re-
sults for Hispanic/Latinos and Asians when compared with
whites increased; differences between whites and African
Americans decreased. Taking all of the preceding adjust-
ments into account, further adjustments for age modestly
increased the differences observed between whites and
African Americans and modestly decreased the differences
between whites and other groups. Surprisingly, once all of
the other stepwise adjustments in these models are per-
formed, the addition of demographic factors, per se, ex-
erted no incremental effects on graft survival. In the final
complete model that accounts for all of the variables listed
in Table 3, the overall adjusted RR of graft failure was 1.12
for African Americans, 0.77 for Hispanic/Latinos and 0.74
for Asians compared with whites.
As discussed earlier, the sequentially adjusted models
were tested in reverse order. These results are shown
in Table 7, and were in general similar to those seen in
Table 6. Adjustment for demographic factors had little im-
pact on the relationships seen in the unadjusted models.
Adjustment for age increased the differences observed be-
tween whites and African Americans and decreased the
differences between whites and other groups. Sequential
adjustments for disease burden, dialysis time, socioeco-
nomic factors, treatment protocols and transplant factors
reduced differences between whites and African Ameri-
cans, but increased differences between whites and the
other race/ethnicity groups. Incremental adjustment for
OPO slightly decreased differences in RR of graft failure
between whites and African Americans. When all other
adjustments were taken into account, there was no dis-
cernible incremental effect for center factors.
These analyses show that African Americans have graft
failure rates at 5 years that are higher than those of all
other racial/ethnic groups, even after adjusting for the vari-
ables listed in Table 3. The adjusted RR of graft failure for
African Americans compared with whites varied from 1.07
to 1.45, depending upon the manner in which variables
were incorporated into the adjusted models (Tables 5–7).
The RR for Hispanic/Latinos and Asians compared with
whites varied much less across the models considered
(Hispanic/Latino: unadjusted RR = 0.83, adjusted RR range
0.74–0.88; Asian: unadjusted RR = 0.75, adjusted RR
range 0.69–0.81). Adjustments for demographic character-
istics, other than age, and for center factors explain few of
these differences. In general, those categories (age, dis-
ease burden, duration of pretransplant dialysis exposure,
socioeconomic factors and treatment protocols) that are
more closely associated with individual patients have a
greater effect on the RR of graft failure than do organ or
transplant-related factors or variables that are more closely
associated with the transplant center or OPO.
Overall, graft survival at 5 years was best for Asians and
Hispanic/Latinos, intermediate for whites and poorest for
African Americans. These differences were not explained
in their entirety by the data from the time of transplant cur-
rently available in the OPTN/SRTR database. The range of
RRs when compared with whites in the unadjusted analy-
ses ranged from an RR of 0.75 for Asians to an RR of 1.35
in African Americans (first line of Tables 6 and 7). In the fully
adjusted models, this range is compressed to an RR of 0.74
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for Asians and 1.12 in African Americans (last line of
Tables 6 and 7). Thus, the covariates explain a greater
portion of the differences observed between African
Americans and whites than between whites and His-
panic/Latinos or between whites and Asians (Tables 6 and
7). Age and duration of pretransplant dialysis exposure
seem to exert the greatest effect on differential outcomes
(Table 5).
Discussion
Sizeable differences in DD kidney transplant outcomes re-
main unaccounted for despite adjustments for the base-
line variables included in these models. It is possible that
inclusion of additional baseline variables, such as more
complete information on existing medical comorbidities,
socioeconomic factors, histocompatibility or measures of
new or posttransplant variables (e.g. assays of metabolic
pathways for immunosuppressive medications, immune
competence, adherence to medical regimen or quality in-
dicators for posttransplant follow-up) might improve the
predictive value of these analyses and explain more of
the observed differences. For example, the prevalence
of gene polymorphisms associated with hypertension (9)
and increased inflammation or drug metabolism (10) vary
across racial and ethnic groups. In addition, adjusting for
posttransplant variables may have the potential to iden-
tify factors that account for some of these racial/ethnic
differences and perhaps identify appropriate posttrans-
plant intervention. It is also possible that, even with more
extensive data collection, some differences may remain
unexplained.
Although much of the difference in outcomes between
racial/ethnic groups can be accounted for by adjusting for
patient differences, the observed unadjusted differences
remain important. Although the adjustments facilitate un-
derstanding of the factors that contribute to the observed
outcome disparities, the differences between racial/ethnic
groups in important variables may themselves reflect in-
equities in the kidney transplant system and merit further
evaluation. For example, the disparities in age and pretrans-
plant dialysis time between whites and minority transplant
recipients may reflect different listing practices or inequal-
ities in access to transplantation. If so, efforts to mitigate
these inequities may, in turn, reduce the gap in outcomes
between racial/ethnic groups.
In summary, access to transplantation differs between
racial/ethnic groups, but the pattern of these differences
varies by organ type. In unadjusted analyses, minority pa-
tients demonstrate persistent decreased access to kid-
ney transplantation, and whites to cardiac transplantation.
Regarding liver transplants, African American and Asians
appear to have increased and growing access, whereas
Hispanic/Latinos have decreased access. Findings of dif-
ferences in access to transplant by race among those
wait-listed for different types of solid organ transplants
should be interpreted with caution. Although ratios above
or below 1.0 quantify differences in access according to
race/ethnicity, specific thresholds that might constitute
clinically meaningful disparities remain undefined. Further,
analyses assessing difference in access did not account
for potential confounders (e.g. severity of illness at time of
presentation or allocation) that could affect interpretation
of these observations on access to transplant.
Graft and patient outcomes also differ between
racial/ethnic groups. The pattern of these differences is
similar for patient survival across organs and for kid-
ney graft survival. In general, Asians followed by His-
panic/Latinos have the best outcomes. Whites have in-
termediate outcomes, superior to those of African Amer-
icans, but lagging behind those observed for Asians and
Hispanic/Latinos. This trend is apparent at multiple time-
points after transplant and is seen with nearly all organ
types.
In our analysis of kidney transplant graft loss, adjustment
for a number of demographic factors could not fully explain
the differences observed between racial/ethnic groups.
Compared with the rates observed for white kidney trans-
plant recipients, adjustments partially accounted for much
of the increased risk of graft loss observed for African
Americans, but explained much less of the superior graft
survival noted for Asians and Hispanic/Latinos. Finally, the
analysis demonstrated differences in the race/ethnicity
composition of the waiting list by a number of categories of
variables and quantified the contribution of these variables
to the outcome disparities seen between racial/ethnic
groups. In the multivariate models, patient-related factors
were, in general, more explanatory than center-related vari-
ables in explaining observed differences in graft survival.
Further initiatives to resolve these inequities may narrow
the racial/ethnic differences in outcomes after organ trans-
plantation.
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